Oaktree Acquisition Corp. III Life Sciences (OACC) · Oct 16, 2026 · Other events
Meeting postponed — October 16 moved to October 23, 2026
Oaktree Acquisition Corp. III postponed its extension vote to October 23, giving shareholders another week to support more time for a deal.
Oaktree Acquisition Corp. III is a blank-check company nearing its October 25, 2026 deadline to complete a business combination, seeking approval to extend that deadline to November 25 and potentially through May 25, 2027. This filing buys the vote—not the deal—another week. The company postponed its October 16 shareholder meeting to October 23 “in order to permit further solicitation and vote of proxies.”
The underlying transaction story is unchanged. Shareholders are still voting on whether to give OAC more time to find and close a business combination; they are not voting on a target company or merger at this meeting. The proxy materials already contemplated adjournment if more votes were needed, so the delay is operationally meaningful but not a new strategic development. 〔0〕
The next hard checkpoint is the rescheduled vote on October 23. The record date remains September 22, and previously submitted proxies remain valid; shareholders can still withdraw redemption requests before the meeting.
Bottom line: This is a procedural delay to improve voter participation, not evidence of a business combination or a change to OAC’s deal prospects. It matters mainly because failure to secure the extension would leave the company facing its October 25 deadline and potential liquidation.
Extension vote on October 23, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!